Post Conference Perspectives: ASH 2024 : Episode 4
Opinion
Video
Discussing Real-World Ruxolitinib and Corticosteroid Treatment Patterns in Patients with cGVHD
Author(s):
Sergio A. Giralt, MD, discusses how he selects patients with chronic graft-vs-host disease (cGVHD) for treatment with ruxolitinib, often in combination with corticosteroids, and reviews the study design and methods of recent research on ruxolitinib in cGVHD management, highlighting key efficacy and safety results and how these findings align with his clinical practice.
Video content above is prompted by the following:
- Which patients with chronic graft-vs-host disease (cGVHD) do you treat with ruxolitinib in your clinical practice?
- Do you use corticosteroids concurrently with ruxolitinib?
- What were this abstract’s study design and methods, and why was it important to investigate for cGVHD management?
- What were the key efficacy and safety results seen in this abstract?
- Do these results align with what you see in your clinical practice?
Related Videos
Related Content
December 26th 2024
